Vir Biotechnology, Inc. expanded its Board of Directors from seven to eight members and appointed Timothy Coughlin, CPA, to a newly created Class III director seat. Mr. Coughlin will also serve as Chair of the Audit Committee. Vir Biotechnology, Inc. is a biotechnology company focused on developing and commercializing infectious disease therapies.
